Kent Pharmaceuticals

  • Date of Transaction: Feb 2013
  • Acquirer: DCC plc
  • Service: M&A

Gordon did a fantastic job advising on a very complex sale involving multiple stakeholders. Gordon's deep sector knowledge and proven execution capabilities were integral to the successful completion of this transaction.

Gordon advised the shareholders of Kent Pharmaceutical (Holdings) Limited, a UK generic pharmaceuticals company, on its sale to DCC Healthcare, a subsidiary of DCC plc, one of Ireland's largest sales, marketing and distribution business support groups for €71.2m.

The deal will significantly increase the scale of DCC's pharma business, bringing in a complementary product portfolio, product licences and strong relationships with UK retail pharmacies. Combined, the two companies will have revenues approaching €150m and a leading position in the UK generics market.

Kent Pharma has a broad portfolio of licensed products with a particular focus on beta lactam antibiotics including penicillin V, flucloxacillin and amoxicillin for treating bacterial infections. The Company also operates Athlone Pharmaceuticals, a specialist beta lactam manufacturing facility located in Roscommon, Ireland.

Commenting on the transaction Mike Overy, Kent Pharmaceutical's Chairman, said:

"Gordon did a fantastic job advising on a very complex sale involving multiple stakeholders. Gordon's deep sector knowledge and proven execution capabilities were integral to the successful completion of this transaction".